Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant metformin added to chemotherapy and trastuzumab for HER2-positive primary breast cancer
2011-000490-30Phase 2Active
- Sponsor
- Institut Català d'Oncologia
- Start
- Feb 2011
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of metformin, trastuzumab and paclitaxel in breast cancer (2 arms), sponsored by Institut Català d'Oncologia. Primary endpoint: Pathological complete response rate. Started Feb 2011; status: active.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-000490-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000490-30.